325 related articles for article (PubMed ID: 36992493)
1. EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors.
Hu K; Onintsoa Diarimalala R; Yao C; Li H; Wei Y
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992493
[TBL] [Abstract][Full Text] [Related]
2. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
3. Effects and mechanism of Aβ
Zhong M; Wang H; Yan H; Wu S; Wang K; Yang L; Cui B; Wu M; Li Y
Virol J; 2022 Sep; 19(1):151. PubMed ID: 36127711
[TBL] [Abstract][Full Text] [Related]
4. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
5. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
7. Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus.
Yeung ML; Jia L; Yip CCY; Chan JFW; Teng JLL; Chan KH; Cai JP; Zhang C; Zhang AJ; Wong WM; Kok KH; Lau SKP; Woo PCY; Lo JYC; Jin DY; Shih SR; Yuen KY
J Clin Invest; 2018 Nov; 128(11):5163-5177. PubMed ID: 30153112
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus A71 does not meet the uncoating receptor SCARB2 at the cell surface.
Nishimura Y; Sato K; Koyanagi Y; Wakita T; Muramatsu M; Shimizu H; Bergelson JM; Arita M
PLoS Pathog; 2024 Feb; 20(2):e1012022. PubMed ID: 38359079
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Dicaffeoylquinic Acid from the Medicinal Plant
Hsieh CF; Chen YL; Lin GH; Chan YF; Hsieh PW; Horng JT
J Virol; 2022 Apr; 96(7):e0054221. PubMed ID: 35319229
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
11. Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.
Helgers LC; Bhoekhan MS; Pajkrt D; Wolthers KC; Geijtenbeek TBH; Sridhar A
Microbiol Spectr; 2022 Dec; 10(6):e0282222. PubMed ID: 36222686
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71).
Masomian M; Lalani S; Poh CL
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770987
[TBL] [Abstract][Full Text] [Related]
13. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
Huang SW; Tai CH; Fonville JM; Lin CH; Wang SM; Liu CC; Su IJ; Smith DJ; Wang JR
J Virol; 2015 Nov; 89(22):11500-6. PubMed ID: 26339057
[TBL] [Abstract][Full Text] [Related]
14. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
15. The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate.
Nishimura Y; McLaughlin NP; Pan J; Goldstein S; Hafenstein S; Shimizu H; Winkler JD; Bergelson JM
PLoS Pathog; 2015 Oct; 11(10):e1005184. PubMed ID: 26430888
[TBL] [Abstract][Full Text] [Related]
16. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.
Volle R; Luo L; Razafindratsimandresy R; Sadeuh-Mba SA; Gouandjika-Valisache I; Horwood P; Duong V; Buchy P; Joffret ML; Huang Z; Duizer E; Martin J; Chakrabarti LA; Dussart P; Jouvenet N; Delpeyroux F; Bessaud M
J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37909282
[TBL] [Abstract][Full Text] [Related]
18. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
Wei Y; Liu H; Hu D; He Q; Yao C; Li H; Hu K; Wang J
Lab Invest; 2024 Feb; 104(2):100298. PubMed ID: 38008182
[TBL] [Abstract][Full Text] [Related]
20. Antigenic mapping of enterovirus A71 from Taiwan and Southeast Asia.
Cheng D; Huang SW; Tsai YH; Lien YY; Wang JR
Antiviral Res; 2023 Apr; 212():105569. PubMed ID: 36822369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]